OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Dermatological Treatment is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis	111
A systematic review of recent randomized controlled trials for palmoplantar pustulosis	65
Skin type classifications: does the perfect assessment exist?	65
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist	50
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy	47
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab	44
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most	44
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial	38
Lessons from a decentralized trial in atopic dermatitis: promises and perils	37
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants	36
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks	34
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)	33
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso	29
Topical delgocitinib for the treatment of chronic hand eczema	28
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa	26
Finally, successful interventions to ameliorate cutaneous infestations	25
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry	23
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)	23
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients	23
Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study	22
A pediatric case of dupilumab-induced pustular psoriasis	22
Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib	21
Rapid improvement of kimura disease with dupilumab in a patient with suboptimal response to mepolizumab: a case report	21
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis	21